SEC Form 4/A · accession 0000899243-19-001157
Invitae Corp · NVTA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
Robert L Nussbaum
Officer — Chief Medical Officer
Period of report
Nov 12, 2018
Accepted (ET)
Jan 14, 2019 · 9:09 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001501134
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2,F3,F4,F5 | Nov 12, 2018 | S | 8,244 | $13.0036 | D | 171,191 | D | |
| Common StockF1,F2,F3,F6,F5 | Nov 12, 2018 | S | 2,200 | $13.5282 | D | 168,991 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1These sales of common stock were effected pursuant to Rule 10b5-1 sales plan adopted by the reporting person on August 10, 2018.
- F2The transaction code was incorrectly reported and transactions not within a one dollar price range were inadvertently aggregated on the reporting person's original Form 4.
- F3Reporting person undertakes to provide upon request by the Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within the range indicated.
- F4Represents weighted average sale price. Actual sale prices ranged from $12.40 to $13.38.
- F5Includes an aggregate of 164,235 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested.
- F6Represents weighted average sale price. Actual sale prices ranged from $13.40 to $13.66.